Diabetes Pill Controls Blood Sugar, Weight Without Heart Risk

GRK-Biased β2AR Agonists: A Safer Pathway for Diabetes Management

A NEW class of oral drugs selectively targeting the β2 adrenergic receptor (β2AR) through a GRK2-biased pathway offers potential advances in the treatment of type 2 diabetes…

Continue Reading